Search
Now showing items 1-7 of 7
“You would not be in a hurry to go back home”: Patients’ willingness to participate in HIV/AIDS clinical trials at a clinical and research facility in Kampala, Uganda
(BMC, 2020)
Background: Few studies have examined factors associated with willingness of people living with HIV (PLHIV) to
participate in HIV treatment clinical trials in Sub-Saharan Africa. We assessed the factors associated with ...
Prevalence and factors associated with dyslipidemia among adult patients on dolutegravir based antiretroviral regimen at Mengo Hospital, A cross-sectional study
(Makerere University, 2022-12)
Introduction: Dolutegravir (DTG) based anti-retroviral therapy (ART) regimen has been rolled out in Uganda as the preferred first- and second-line treatment option in the management of Human Immunodeficiency Virus (HIV). ...
Haematological recovery among people living with HIV after Cotrimoxazole prophylaxis discontinuation at Infectious Diseases Institute, An urban HIV Care Centre, in Uganda
(Makerere University, 2022-08)
ABSTRACT
Introduction:
Co-trimoxazole (CTX) prophylaxis has been part of the minimum care package for HIV-infected patients in Africa since 2001. Both World Health Organization (WHO) and Uganda’s national HIV guidelines ...
Clinical, immunological, virological characteristics, and hospitalisation outcomes of patients admitted to Kiruddu Hospital with advanced HIV disease
(Makerere University, 2022-08)
Introduction
Nearly four decades after the first case of AIDS was described, the global number of AIDS related deaths is not declining as expected to meet elimination targets, especially in sub-Saharan Africa where the ...
Prevalence and factors influencing suboptimal adherence to dolutegravir-based regimens among adult patients at Joint Clinical Research Center, Lubowa
(Makerere University, 2022-12)
Background: An estimated 37.7 million people are living with HIV globally with the majority being in sub-Saharan Africa. There is a need to address suboptimal adherence to prevent dolutegravir resistance in order to maintain ...
Longitudinal patients’ cohorts for impactful research and HIV care at the Infectious Diseases Institute
(2022)
Introduction
Observational studies provide important evidence supporting the feasibility and effectiveness of health interventions. The 20-year-old Infectious Diseases Institute (IDI) established to respond to infectious ...
Stigma mastery in people living with HIV: gender similarities and theory
(Springer, 2021)
Aims: This study aimed to determine the prevalence of, factors associated with, and to build a theoretical framework for understanding Internalized HIV-related Stigma Mastery (IHSM).
Methods: A cross-sectional study nested ...